Vivos gets approvals to enable Medicare reimbursement for CARE oral devices

Vivos Therapeutics announced receipt of all required regulatory approvals to enable Medicare reimbursement for its CARE oral medical devices. Effective immediately, this milestone achievement allows millions of Medicare…Vivos provider and nationally renowned medical billing expert Chris Farrugia, DDS, DABSB, commented, “This coding decision from CMS now aligns with standard commercial billing practices for the device under the code K1027 as an oral device appliance used to reduce upper airway collapsibility, without a fixed mechanical hinge. This is a big step in making Vivos’ therapy accessible to Medicare beneficiaries as well as the millions of OSA patients covered by commercial insurers.”